|
Immunohistochemical markers in the differential diagnosis of MCC. |
||||||||||
| CK-20 |
TTF-1 |
NSE |
S-100 |
GrA |
SYP |
NFP |
CD56 |
MAP-2 |
LCA |
|
|
|
||||||||||
| MCC |
+ |
- |
+ |
- |
+/- |
+/- |
+ |
+ |
+ |
- |
| SCLC |
- |
+ |
+/- |
- |
-/+ |
+ |
-/+ |
+ |
+ |
- |
| MM |
- |
- |
- |
+ |
- |
- |
+ |
- |
||
| LGNEC |
+ |
+ |
+ |
+ |
-/+ |
|||||
| Malignant lymphoma |
- |
- |
- |
- |
- |
-/+ |
+ |
|||
|
+ positive, +/- mostly positive, -/+ mostly negative, - negative. CK-20 cytokeratin 20, TTF-1 thyroid transcription factor 1, NSE neuron-spesific enolase, GrA gromogranin A, NFP neurofilament proteins, CD56 neural adhesion molecule, MAP-2 microtubule associated protein 2, LCA leukocyte common antigen SCLC small cell lung carcinoma, MM malignant melanoma, LGNEC low grade neuroendocrine carcinomas | ||||||||||
Koljonen World Journal of Surgical Oncology 2006 4:7 doi:10.1186/1477-7819-4-7 |
||||||||||